decreased incidence of induced tumors Gene Set

Dataset MPO Gene-Phenotype Associations
Category disease or phenotype associations
Type phenotype
Description reduced frequency of tumor incidence induced by a carcinogen, mutagen or virus (Mammalian Phenotype Ontology, MP_0002053)
External Link http://www.informatics.jax.org/searches/Phat.cgi?id=MP:0002053
Similar Terms
Downloads & Tools

Genes

70 gene mutations causing the decreased incidence of induced tumors phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset.

Symbol Name
AFP alpha-fetoprotein
AGTR2 angiotensin II receptor, type 2
AHRR aryl-hydrocarbon receptor repressor
AR androgen receptor
ARL6IP5 ADP-ribosylation factor-like 6 interacting protein 5
ASIP agouti signaling protein
BRCA2 breast cancer 2, early onset
CACFD1 calcium channel flower domain containing 1
CCL13 chemokine (C-C motif) ligand 13
CCNG1 cyclin G1
CD151 CD151 molecule (Raph blood group)
CD34 CD34 molecule
CDKN1A cyclin-dependent kinase inhibitor 1A (p21, Cip1)
CDKN1B cyclin-dependent kinase inhibitor 1B (p27, Kip1)
CDKN2A cyclin-dependent kinase inhibitor 2A
CEBPB CCAAT/enhancer binding protein (C/EBP), beta
COPS6 COP9 signalosome subunit 6
CYP1A2 cytochrome P450, family 1, subfamily A, polypeptide 2
CYP1B1 cytochrome P450, family 1, subfamily B, polypeptide 1
CYP2E1 cytochrome P450, family 2, subfamily E, polypeptide 1
DEK DEK proto-oncogene
EIF2S2 eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa
EPHX1 epoxide hydrolase 1, microsomal (xenobiotic)
FGF22 fibroblast growth factor 22
FOXN1 forkhead box N1
FZR1 fizzy/cell division cycle 20 related 1 (Drosophila)
HCST hematopoietic cell signal transducer
HIPK1 homeodomain interacting protein kinase 1
HRAS Harvey rat sarcoma viral oncogene homolog
IER3 immediate early response 3
IL10 interleukin 10
IL12B interleukin 12B
IL1R1 interleukin 1 receptor, type I
IL23A interleukin 23, alpha subunit p19
IL6 interleukin 6
IL6R interleukin 6 receptor
ITGB1 integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
KRT10 keratin 10, type I
LRIG2 leucine-rich repeats and immunoglobulin-like domains 2
MGAT3 mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase
MIF macrophage migration inhibitory factor (glycosylation-inhibiting factor)
MMP1 matrix metallopeptidase 1
MMP11 matrix metallopeptidase 11
MMP19 matrix metallopeptidase 19
MPG N-methylpurine-DNA glycosylase
MYD88 myeloid differentiation primary response 88
NEU3 sialidase 3 (membrane sialidase)
PGR progesterone receptor
PIK3CA phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
PLA2G4A phospholipase A2, group IVA (cytosolic, calcium-dependent)
PLCE1 phospholipase C, epsilon 1
PTGER1 prostaglandin E receptor 1 (subtype EP1), 42kDa
PTGER2 prostaglandin E receptor 2 (subtype EP2), 53kDa
PTGER4 prostaglandin E receptor 4 (subtype EP4)
PTGS2 prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
PTP4A3 protein tyrosine phosphatase type IVA, member 3
PTPRJ protein tyrosine phosphatase, receptor type, J
PVR poliovirus receptor
RALGDS ral guanine nucleotide dissociation stimulator
SKIL SKI-like proto-oncogene
SPP1 secreted phosphoprotein 1
STAG1 stromal antigen 1
TERC telomerase RNA component
TERT telomerase reverse transcriptase
TIAM1 T-cell lymphoma invasion and metastasis 1
TLR4 toll-like receptor 4
TNF tumor necrosis factor
TP53 tumor protein p53
TREM1 triggering receptor expressed on myeloid cells 1
TRIM27 tripartite motif containing 27